Abstract

Intensive diabetes control has been associated with increased mortality in type 2 diabetes (T2DM); this has been suggested to be due to increased hypoglycemia. We measured hypoglycemia-induced changes in endothelial parameters, oxidative stress markers and inflammation at baseline and after a 24-hour period in type 2 diabetic (T2DM) subjects versus age-matched controls. Case-control study: 10 T2DM and 8 control subjects. Blood glucose was reduced from 5 (90 mg/dl) to hypoglycemic levels of 2.8 mmol/L (50 mg/dl) for 1 hour by incremental hyperinsulinemic clamps using baseline and 24 hour samples. Measures of endothelial parameters, oxidative stress and inflammation at baseline and at 24-hours post hypoglycemia were performed: proteomic (Somalogic) analysis for inflammatory markers complemented by C-reactive protein (hsCRP) measurement, and proteomic markers and urinary isoprostanes for oxidative measures, together with endothelial function. Between baseline and 24 -hours after hypoglycemia, 15 of 140 inflammatory proteins differed in T2DM whilst only 1 of 140 differed in controls; all returned to baseline at 24-hours. However, elevated hsCRP levels were seen at 24-hours in T2DM (2.4 mg/L (1.2–5.4) vs. 3.9 mg/L (1.8–6.1), Baseline vs 24-hours, P < 0.05). In patients with T2DM, between baseline and 24-hour after hypoglycemia, only one of 15 oxidative stress proteins differed and this was not seen in controls. An increase (P = 0.016) from baseline (73.4 ng/mL) to 24 hours after hypoglycemia (91.7 ng/mL) was seen for urinary isoprostanes. Hypoglycemia resulted in inflammatory and oxidative stress markers being elevated in T2DM subjects but not controls 24-hours after the event.

Details

Title
Effect of induced hypoglycemia on inflammation and oxidative stress in type 2 diabetes and control subjects
Author
Kahal Hassan 1 ; Halama, Anna 2 ; Aburima Ahmed 3 ; Bhagwat, Aditya M 2 ; Butler, Alexandra E 4 ; Graumann Johannes 5 ; Suhre Karsten 6 ; Thozhukat, Sathyapalan 7 ; Atkin, Stephen L 8 

 Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801); Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801) 
 Weill Cornell Medicine Qatar, Education City, PO, Doha, Qatar (GRID:grid.413631.2) 
 Centre for Cardiovascular and Metabolic Research, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801) 
 Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box, Doha, Qatar (GRID:grid.418818.c) (ISNI:0000 0001 0516 2170) 
 Proteomics Core, Weill Cornell Medicine-Qatar, Education City, PO Box, Doha, Qatar (GRID:grid.418818.c); Scientific Service Group Biomolecular Mass Spectrometry, Max Planck Institute for Heart and Lung Research, Ludwigstr. 43, Bad Nauheim, Germany (GRID:grid.418032.c) (ISNI:0000 0004 0491 220X) 
 Proteomics Core, Weill Cornell Medicine-Qatar, Education City, PO Box, Doha, Qatar (GRID:grid.418032.c) 
 Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK (GRID:grid.413631.2) (ISNI:0000 0000 9468 0801) 
 Royal College of Surgeon in Ireland, Manama, Bahrain (GRID:grid.413631.2) 
Publication year
2020
Publication date
2020
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2377672490
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.